Impact of MCP-1 in atherosclerosis.

Curr Pharm Des

The Mary and Garry Weston Molecular Immunology Laboratory, Thrombosis Research Institute, London, SW3 6LR, United Kingdom.

Published: February 2015

Monocyte chemotactic protein-1 (MCP-1) (also referred to as chemokine (C-C motif) ligand 2 (CCL2) is expressed by mainly inflammatory cells and endothelial cells. The expression level is upregulated after proinflammatory stimuli and tissue injury which are associated with atherosclerotic lesion. Atherosclerosis is a progressive disease starting with accumulation of lipids, lipoproteins, and immune cells in the arterial wall. MCP-1 has been reported to play an important role in the pathogenesis of atherosclerosis and considerable evidence supports that the monocyte containing MCPs and macrophage influences the growth of other cell types within the atherosclerotic lesion. This review will focus on the general structure features of MCP-1 and its role in atherosclerosis.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612820666140522115801DOI Listing

Publication Analysis

Top Keywords

atherosclerotic lesion
8
impact mcp-1
4
atherosclerosis
4
mcp-1 atherosclerosis
4
atherosclerosis monocyte
4
monocyte chemotactic
4
chemotactic protein-1
4
protein-1 mcp-1
4
mcp-1 referred
4
referred chemokine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!